Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055968511> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2055968511 endingPage "331" @default.
- W2055968511 startingPage "331" @default.
- W2055968511 abstract "<h3>ABSTRACT</h3> <h3>Background</h3> Altered metabolism of acylcarnitines – transporting fatty acids to mitochondria – may link cellular energy dysfunction to depression. We examined the potential causal role of acylcarnitine metabolism in depression by leveraging genomics and Mendelian randomization. <h3>Methods</h3> Summary statistics were obtained from large GWAS: the Fenland Study (N= 9,363), and the Psychiatric Genomics Consortium (246,363 depression cases and 561,190 controls). Two-sample Mendelian randomization analyses tested the potential causal link of 15 endogenous acylcarnitines with depression. <h3>Results</h3> In univariable analyses, genetically-predicted lower levels of short-chain acylcarnitines C2 (Odds Ratio [OR] 0.97, 95% Confidence Intervals [CIs] 0.95-1.00) and C3 (OR 0.97, 95%CIs 0.96-0.99) and higher levels of medium-chain acylcarnitines C8 (OR 1.04, 95%CIs 1.01-1.06) and C10 (OR 1.04, 95%CIs 1.02-1.06) were associated with increased depression risk. No reverse potential causal role of depression genetic liability on acylcarnitines levels was found. Multivariable analyses showed that the association with depression was driven by the medium-chain acylcarnitines C8 (OR 1.04, 95%CIs 1.02-1.06) and C10 (OR 1.04, 95%CIs 1.02-1.06), suggesting a potential causal role in the risk of depression. Causal estimates for C8 (OR=1.05, 95%CIs=1.02-1.07) and C10 (OR=1.05, 95%CIs=1.02-1.08) were confirmed in follow-up analyses using genetic instruments derived from a GWAS meta-analysis including up to 16,841 samples. <h3>Discussion</h3> Accumulation of medium-chain acylcarnitines is a signature of inborn errors of fatty acid metabolism and age-related metabolic conditions. Our findings point to a link between altered mitochondrial energy production and depression pathogenesis. Acylcarnitine metabolism represents a promising access point for the development of novel therapeutic approaches for depression." @default.
- W2055968511 created "2016-06-24" @default.
- W2055968511 creator A5074941749 @default.
- W2055968511 date "1974-05-11" @default.
- W2055968511 modified "2023-09-25" @default.
- W2055968511 title "Isolation System for General Hospitals" @default.
- W2055968511 doi "https://doi.org/10.1136/bmj.2.5914.331-a" @default.
- W2055968511 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1610964" @default.
- W2055968511 hasPublicationYear "1974" @default.
- W2055968511 type Work @default.
- W2055968511 sameAs 2055968511 @default.
- W2055968511 citedByCount "3" @default.
- W2055968511 crossrefType "journal-article" @default.
- W2055968511 hasAuthorship W2055968511A5074941749 @default.
- W2055968511 hasBestOaLocation W20559685112 @default.
- W2055968511 hasConcept C104317684 @default.
- W2055968511 hasConcept C106208931 @default.
- W2055968511 hasConcept C118552586 @default.
- W2055968511 hasConcept C126322002 @default.
- W2055968511 hasConcept C134018914 @default.
- W2055968511 hasConcept C135763542 @default.
- W2055968511 hasConcept C139719470 @default.
- W2055968511 hasConcept C153209595 @default.
- W2055968511 hasConcept C156957248 @default.
- W2055968511 hasConcept C162324750 @default.
- W2055968511 hasConcept C2776867660 @default.
- W2055968511 hasConcept C2779901538 @default.
- W2055968511 hasConcept C2993967602 @default.
- W2055968511 hasConcept C44249647 @default.
- W2055968511 hasConcept C54355233 @default.
- W2055968511 hasConcept C60644358 @default.
- W2055968511 hasConcept C71924100 @default.
- W2055968511 hasConcept C86803240 @default.
- W2055968511 hasConceptScore W2055968511C104317684 @default.
- W2055968511 hasConceptScore W2055968511C106208931 @default.
- W2055968511 hasConceptScore W2055968511C118552586 @default.
- W2055968511 hasConceptScore W2055968511C126322002 @default.
- W2055968511 hasConceptScore W2055968511C134018914 @default.
- W2055968511 hasConceptScore W2055968511C135763542 @default.
- W2055968511 hasConceptScore W2055968511C139719470 @default.
- W2055968511 hasConceptScore W2055968511C153209595 @default.
- W2055968511 hasConceptScore W2055968511C156957248 @default.
- W2055968511 hasConceptScore W2055968511C162324750 @default.
- W2055968511 hasConceptScore W2055968511C2776867660 @default.
- W2055968511 hasConceptScore W2055968511C2779901538 @default.
- W2055968511 hasConceptScore W2055968511C2993967602 @default.
- W2055968511 hasConceptScore W2055968511C44249647 @default.
- W2055968511 hasConceptScore W2055968511C54355233 @default.
- W2055968511 hasConceptScore W2055968511C60644358 @default.
- W2055968511 hasConceptScore W2055968511C71924100 @default.
- W2055968511 hasConceptScore W2055968511C86803240 @default.
- W2055968511 hasIssue "5914" @default.
- W2055968511 hasLocation W20559685111 @default.
- W2055968511 hasLocation W20559685112 @default.
- W2055968511 hasOpenAccess W2055968511 @default.
- W2055968511 hasPrimaryLocation W20559685111 @default.
- W2055968511 hasRelatedWork W2019986657 @default.
- W2055968511 hasRelatedWork W2216913878 @default.
- W2055968511 hasRelatedWork W2562476763 @default.
- W2055968511 hasRelatedWork W2574750590 @default.
- W2055968511 hasRelatedWork W2899096266 @default.
- W2055968511 hasRelatedWork W3125792281 @default.
- W2055968511 hasRelatedWork W4220909168 @default.
- W2055968511 hasRelatedWork W4221090191 @default.
- W2055968511 hasRelatedWork W4285264691 @default.
- W2055968511 hasRelatedWork W4309436704 @default.
- W2055968511 hasVolume "2" @default.
- W2055968511 isParatext "false" @default.
- W2055968511 isRetracted "false" @default.
- W2055968511 magId "2055968511" @default.
- W2055968511 workType "article" @default.